P. Soni

Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation.

J. Rabinowitz, D. Spyker, P. Munzar, 2006, Journal of pharmaceutical sciences.

Development of budesonide nanocluster dry powder aerosols: processing.

C. Berkland, N. El-gendy, P. Selvam, 2012, Journal of pharmaceutical sciences.

Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study

S. K. Mendiratta, J. Patel, Shashank R Joshi, 2021, International Journal of Infectious Diseases.

Efficacy and safety of polyherbal formulation as an add-on to standard-of-care in mild-to-moderate COVID-19: A randomized, double-blind, placebo-controlled trial

K. Joshi, T. Shah, R. Raje, 2021, Journal of Ayurveda and Integrative Medicine.

Development of budesonide nanocluster dry powder aerosols: formulation and stability.

Sha Huang, C. Berkland, N. El-gendy, 2012, Journal of pharmaceutical sciences.